Clinical presentation and treatment of type 2 diabetes in children

被引:152
作者
Pinhas-Hamiel, Orit
Zeitler, Phil
机构
[1] Univ Colorado, Sch Med, Childrens Hosp, Div Endocrinol, Aurora, CO 80045 USA
[2] Chaim Sheba Med Ctr, Safra Childrens Hosp, Pediat Endocrinol & Diabet Unit, Ramat Gan, Israel
[3] Maccabi Juvenile Diabet Ctr, Raanana, Israel
关键词
diet; exercise; medications; presentation; treatment; type; 2; diabetes;
D O I
10.1111/j.1399-5448.2007.00330.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes mellitus (T2DM) has dramatically increased throughout the world in many ethnic groups and among people with diverse social and economic backgrounds. This increase has also affected the young such that over the past decade, the increase in the number of children and youth with T2DM has been labeled an 'epidemic'. Before the 1990s, it was rare for most pediatric centers to have significant numbers of patients with T2DM. However, by 1994, T2DM patients represented up to 16% of new cases of diabetes in children in urban areas and by 1999, depending on geographic location, the range of percentage of new cases because of T2DM was 8-45% and disproportionately represented among minority populations. Although the diagnosis was initially regarded with skepticism, T2DM is now a serious diagnostic consideration in all young people who present with signs and symptoms of diabetes in the USA.
引用
收藏
页码:16 / 27
页数:12
相关论文
共 68 条
[41]   Thiazolidinediones and type 2 diabetes: new drugs for an old disease [J].
O'Moore-Sullivan, TM ;
Prins, JB .
MEDICAL JOURNAL OF AUSTRALIA, 2002, 176 (08) :381-386
[42]   Clinical evidence of thiazolidinedione-induced improvement of pancreatic β-cell function in patients with type 2 diabetes mellitus [J].
Ovalle, F ;
Bell, DSH .
DIABETES OBESITY & METABOLISM, 2002, 4 (01) :56-59
[43]   Treatment of NIDDM in youth [J].
Owada, M ;
Nitadori, Y ;
Kitagawa, T .
CLINICAL PEDIATRICS, 1998, 37 (02) :117-121
[44]  
Pettigrew D C, 2001, Pediatr Rev, V22, P169
[45]   The global spread of type 2 diabetes mellitus in children and adolescents [J].
Pinhas-Hamiel, O ;
Zeitler, P .
JOURNAL OF PEDIATRICS, 2005, 146 (05) :693-700
[46]   The type 2 family -: A setting for development and treatment of adolescent type 2 diabetes mellitus [J].
Pinhas-Hamiel, O ;
Standiford, D ;
Hamiel, D ;
Dolan, LM ;
Cohen, R ;
Zeitler, PS .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1999, 153 (10) :1063-1067
[47]   Acute necrotizing pancreatitis in an adolescent with type 2 diabetes [J].
Pinhas-Hamiel, Orit ;
Chernausek, Steven D. ;
Zeitler, Philip .
CURRENT OPINION IN PEDIATRICS, 2006, 18 (02) :206-208
[48]   Diabetic ketoacidosis among obese African-American adolescents with NIDDM [J].
PinhasHamiel, O ;
Dolan, LM ;
Zeitler, PS .
DIABETES CARE, 1997, 20 (04) :484-486
[49]   A pilot study of ploglitazone treatment for nonalcoholic steatohepatitis [J].
Promrat, K ;
Lutchman, G ;
Uwaifo, GI ;
Freedman, RJ ;
Soza, A ;
Heller, T ;
Doo, E ;
Ghany, M ;
Premkumar, A ;
Park, Y ;
Liang, TJ ;
Yanovski, JA ;
Kleiner, DE ;
Hoofnagle, JH .
HEPATOLOGY, 2004, 39 (01) :188-196
[50]   β-cell autoantibodies in children with type 2 diabetes mellitus:: subgroup or misclassification? [J].
Reinehr, T. ;
Schober, E. ;
Wiegand, S. ;
Thon, A. ;
Holl, R. .
ARCHIVES OF DISEASE IN CHILDHOOD, 2006, 91 (06) :473-477